Abstract
MORE than 30 drugs in current clinical use, other than those used in anesthesia, may interfere with neuromuscular transmission. This complication of drug therapy is unusual but has been well documented; over 200 cases have been reported.1 Awareness of the possibility of such an effect is important, since failure to recognize that a drug is responsible for, or is contributing to, a myasthenic syndrome may lead to unnecessary morbidity and even to a fatal outcome in what is potentially a reversible condition. Although clinically manifest neuromuscular blockade is uncommon, subclinical involvement is probably more frequent than is generally appreciated. Clinical . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
